The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Etoricoxib Teva 120 mg film-coated tablets



Teva B.V.PA1986/002/004

Main Information

Trade NameEtoricoxib Teva 120 mg film-coated tablets
Active SubstancesEtoricoxib
Dosage FormFilm-coated tablet
Licence HolderTeva B.V.
Licence NumberPA1986/002/004

Group Information

ATC CodeM01AH Coxibs
M01AH05 etoricoxib

Status

License statusAuthorised
Licence Issued19/02/2016
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0108-167-003
Interchangeable List DocumentPDF of Interchangeable List
« Back